Evaluation of in vivo pharmacokinetic study of the anti-cancer drug imatinib using silkworms as an animal model
{{output}}
Imatinib is an oral molecular targeted therapy that acts as a tyrosine kinase inhibitor. Silkworms present a promising experimental model for elucidating the pharmacokinetic and toxicity profiles of various compounds. This study aimed to establish an experimen... ...
